Cargando…
Computational disease modeling – fact or fiction?
BACKGROUND: Biomedical research is changing due to the rapid accumulation of experimental data at an unprecedented scale, revealing increasing degrees of complexity of biological processes. Life Sciences are facing a transition from a descriptive to a mechanistic approach that reveals principles of...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697138/ https://www.ncbi.nlm.nih.gov/pubmed/19497118 http://dx.doi.org/10.1186/1752-0509-3-56 |
_version_ | 1782168289681604608 |
---|---|
author | Tegnér, Jesper N Compte, Albert Auffray, Charles An, Gary Cedersund, Gunnar Clermont, Gilles Gutkin, Boris Oltvai, Zoltán N Stephan, Klaas Enno Thomas, Randy Villoslada, Pablo |
author_facet | Tegnér, Jesper N Compte, Albert Auffray, Charles An, Gary Cedersund, Gunnar Clermont, Gilles Gutkin, Boris Oltvai, Zoltán N Stephan, Klaas Enno Thomas, Randy Villoslada, Pablo |
author_sort | Tegnér, Jesper N |
collection | PubMed |
description | BACKGROUND: Biomedical research is changing due to the rapid accumulation of experimental data at an unprecedented scale, revealing increasing degrees of complexity of biological processes. Life Sciences are facing a transition from a descriptive to a mechanistic approach that reveals principles of cells, cellular networks, organs, and their interactions across several spatial and temporal scales. There are two conceptual traditions in biological computational-modeling. The bottom-up approach emphasizes complex intracellular molecular models and is well represented within the systems biology community. On the other hand, the physics-inspired top-down modeling strategy identifies and selects features of (presumably) essential relevance to the phenomena of interest and combines available data in models of modest complexity. RESULTS: The workshop, "ESF Exploratory Workshop on Computational disease Modeling", examined the challenges that computational modeling faces in contributing to the understanding and treatment of complex multi-factorial diseases. Participants at the meeting agreed on two general conclusions. First, we identified the critical importance of developing analytical tools for dealing with model and parameter uncertainty. Second, the development of predictive hierarchical models spanning several scales beyond intracellular molecular networks was identified as a major objective. This contrasts with the current focus within the systems biology community on complex molecular modeling. CONCLUSION: During the workshop it became obvious that diverse scientific modeling cultures (from computational neuroscience, theory, data-driven machine-learning approaches, agent-based modeling, network modeling and stochastic-molecular simulations) would benefit from intense cross-talk on shared theoretical issues in order to make progress on clinically relevant problems. |
format | Text |
id | pubmed-2697138 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26971382009-06-16 Computational disease modeling – fact or fiction? Tegnér, Jesper N Compte, Albert Auffray, Charles An, Gary Cedersund, Gunnar Clermont, Gilles Gutkin, Boris Oltvai, Zoltán N Stephan, Klaas Enno Thomas, Randy Villoslada, Pablo BMC Syst Biol Commentary BACKGROUND: Biomedical research is changing due to the rapid accumulation of experimental data at an unprecedented scale, revealing increasing degrees of complexity of biological processes. Life Sciences are facing a transition from a descriptive to a mechanistic approach that reveals principles of cells, cellular networks, organs, and their interactions across several spatial and temporal scales. There are two conceptual traditions in biological computational-modeling. The bottom-up approach emphasizes complex intracellular molecular models and is well represented within the systems biology community. On the other hand, the physics-inspired top-down modeling strategy identifies and selects features of (presumably) essential relevance to the phenomena of interest and combines available data in models of modest complexity. RESULTS: The workshop, "ESF Exploratory Workshop on Computational disease Modeling", examined the challenges that computational modeling faces in contributing to the understanding and treatment of complex multi-factorial diseases. Participants at the meeting agreed on two general conclusions. First, we identified the critical importance of developing analytical tools for dealing with model and parameter uncertainty. Second, the development of predictive hierarchical models spanning several scales beyond intracellular molecular networks was identified as a major objective. This contrasts with the current focus within the systems biology community on complex molecular modeling. CONCLUSION: During the workshop it became obvious that diverse scientific modeling cultures (from computational neuroscience, theory, data-driven machine-learning approaches, agent-based modeling, network modeling and stochastic-molecular simulations) would benefit from intense cross-talk on shared theoretical issues in order to make progress on clinically relevant problems. BioMed Central 2009-06-04 /pmc/articles/PMC2697138/ /pubmed/19497118 http://dx.doi.org/10.1186/1752-0509-3-56 Text en Copyright © 2009 Tegnér et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Tegnér, Jesper N Compte, Albert Auffray, Charles An, Gary Cedersund, Gunnar Clermont, Gilles Gutkin, Boris Oltvai, Zoltán N Stephan, Klaas Enno Thomas, Randy Villoslada, Pablo Computational disease modeling – fact or fiction? |
title | Computational disease modeling – fact or fiction? |
title_full | Computational disease modeling – fact or fiction? |
title_fullStr | Computational disease modeling – fact or fiction? |
title_full_unstemmed | Computational disease modeling – fact or fiction? |
title_short | Computational disease modeling – fact or fiction? |
title_sort | computational disease modeling – fact or fiction? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697138/ https://www.ncbi.nlm.nih.gov/pubmed/19497118 http://dx.doi.org/10.1186/1752-0509-3-56 |
work_keys_str_mv | AT tegnerjespern computationaldiseasemodelingfactorfiction AT comptealbert computationaldiseasemodelingfactorfiction AT auffraycharles computationaldiseasemodelingfactorfiction AT angary computationaldiseasemodelingfactorfiction AT cedersundgunnar computationaldiseasemodelingfactorfiction AT clermontgilles computationaldiseasemodelingfactorfiction AT gutkinboris computationaldiseasemodelingfactorfiction AT oltvaizoltann computationaldiseasemodelingfactorfiction AT stephanklaasenno computationaldiseasemodelingfactorfiction AT thomasrandy computationaldiseasemodelingfactorfiction AT villosladapablo computationaldiseasemodelingfactorfiction |